For: | Rai V, Mukherjee S. Targets of immunotherapy for hepatocellular carcinoma: An update. World J Hepatol 2022; 14(1): 140-157 [PMID: 35126844 DOI: 10.4254/wjh.v14.i1.140] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i1/140.htm |
Number | Citing Articles |
1 |
Jun Huang, Chunbei Zhao, Xinhe Zhang, Qiaohui Zhao, Yanting Zhang, Liping Chen, Guifu Dai. Hepatitis B virus pathogenesis relevant immunosignals uncovering amino acids utilization related risk factors guide artificial intelligence-based precision medicine. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1079566
|
2 |
Giulia Milardi, Ana Lleo. Tumor-Infiltrating B Lymphocytes: Promising Immunotherapeutic Targets for Primary Liver Cancer Treatment. Cancers 2023; 15(7): 2182 doi: 10.3390/cancers15072182
|
3 |
Zhuoyang Fan, Bowen Yin, Xiaochen Chen, Guowei Yang, Wei Zhang, Xiaodan Ye, Hong Han, Ming Li, Minfeng Shu, Rong Liu. Comprehensive analysis of paraspeckle-associated gene modules unveils prognostic signatures and immunological relevance in multi-cancers. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01188-6
|
4 |
Haiwei Zhang, Juan Zhao, Wei Yang, Zheng Li, Li Gong, Yongsheng Li. Hepatobiliary Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2022; 3: 41 doi: 10.1007/16833_2022_96
|
5 |
Elias Kouroumalis, Ioannis Tsomidis, Argryro Voumvouraki. Is There a Place for Somatostatin Analogues for the Systemic Treatment of Hepatocellular Carcinoma in the Immunotherapy Era?. Livers 2022; 2(4): 315 doi: 10.3390/livers2040024
|
6 |
|
7 |
Mengxing Cai, Jingwen Luo, Chunxiu Yang, Xiaopeng Yang, Cheng Zhang, Lixin Ma, Yibin Cheng. ABHD12 contributes to tumorigenesis and sorafenib resistance by preventing ferroptosis in hepatocellular carcinoma. iScience 2023; 26(12): 108340 doi: 10.1016/j.isci.2023.108340
|